文献速递其他结缔组织病

川崎病初始联合治疗中早期减停糖皮质激素的效果

Effects of early steroid reduction in initial combination therapy for Kawasaki disease.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该回顾性研究分析了104例IVIG无反应高风险川崎病患儿,接受本院6天内减停糖皮质激素的方案。23例(22.1%)出现川崎病症状复发,仅1例(占总数的1.0%)在减停激素后复发;发病1个月时2例(2.0%)观察到冠状动脉病变,均为小型短暂性冠状动脉瘤。作者认为在炎症反应充分控制的情况下,可能可以比既往研究更快地减停激素而不影响治疗结局。

要点

  • 104例IVIG无反应高风险川崎病患儿中,23例(22.1%)出现川崎病症状复发。
  • 仅1例(占总数的1.0%)在减停激素后出现症状复发。
  • 发病1个月时2例(2.0%)观察到冠状动脉病变,均为小型短暂性冠状动脉瘤。

核心结论

  • 在炎症反应已充分控制的情况下,可能可以比既往研究所述更快地减停激素治疗而不影响治疗结局。

研究设计与样本

  • 回顾性研究,纳入2016年6月至2023年9月本院收治的359例新诊断川崎病患者,其中120例被归类为IVIG无反应高风险,104例符合纳入标准并进行分析。

主要发现

  • 104例患者中,23例(22.1%)出现川崎病症状复发。
  • 复发的23例中,仅1例(占总数的1.0%)在减停激素后出现症状复发。
  • 发病1个月时,2例(2.0%)观察到冠状动脉病变,均为小型短暂性冠状动脉瘤。
  • 本研究中心的做法是:一旦炎症充分控制,即在6天内减停激素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In recent years, the use of steroids as an initial adjunctive therapy for patients with Kawasaki disease (KD) at high risk of being unresponsive to intravenous immunoglobulin (IVIG) has shown promising outcomes. However, the optimal duration and tapering method of steroid therapy have not been thoroughly investigated. While the Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy study, which followed the most prominent protocol in Japan, tapers and discontinues steroids for >15 days, our institution reduces and discontinues steroids over six days once inflammation is adequately controlled. In this study, we aimed to determine the effects of our protocol of steroid tapering in initial combination therapy for KD. METHODS: The medical records of 359 patients newly diagnosed with KD admitted to our institute between June 2016 and September 2023 were retrospectively reviewed. Among them, 120 patients were classified as being at high risk of IVIG non-response, and 104 patients who met the inclusion criteria were analysed. RESULTS: Of the 104 patients, 23 (22.1%) experienced a recurrence of KD symptoms. Of these, only one patient (1.0% of the total) exhibited symptom recurrence after steroid tapering. One month after the onset of KD, coronary artery lesions were observed in two patients (2.0%), both of whom had small transient coronary artery aneurysms. CONCLUSION: In cases in which the inflammatory response has been adequately controlled, it may be possible to taper steroid therapy faster than stated in previous studies without compromising treatment outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Shimoyama T, Nakagawa R, Amano S, et al. Effects of early steroid reduction in initial combination therapy for Kawasaki disease. Rheumatology (Oxford). 2025. PMID: 40036957. doi:10.1093/rheumatology/keaf124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。